Human respiratory syncytial virus (HRSV) is the most common cause of serious acute lower respiratory tract disease among infants and young children, and is found mainly in late fall, winter, and spring in temperate zones of the world (6) . Some 50% to 70% of infants experience infection in the first year of life, and virtually all are infected by 2 years of age (3) . In a population-based birth cohort study, 1.1% of the cohort were admitted to the hospital within 12 months of birth with HRSV-induced bronchiolitis (14) . The consequences of HRSV infection in children with underlying conditions, such as prematurity, cardiac and pulmonary disease, or immunosuppression, may include prolonged substantial illness and even death (18, 38) . Reinfections are very common throughout life (7, 10, 11, 13) .
HRSV belongs to the family Paramyxoviridae and has a nonsegmented, negative-sense RNA genome of approximately 15, 200 nucleotides (3) . HRSV has been classified into antigenic subgroups A and B (HRSV-A and HRSV-B, respectively), initially on the basis of the reactivity of the virus with monoclonal antibodies directed against the attachment glycoprotein (G protein) (1, 5, 15, 21) and now by genetic analyses (9, 19, (31) (32) (33) .
The G protein is the most variable HRSV protein, with two hypervariable regions. Its C-terminal region (the second hypervariable region) accounts for strain-specific epitopes (2-4, 9, 16, 27, 29, 31) . The molecular epidemiology and evolutionary patterns of the G protein have provided important information about the epidemiological features of HRSV. Some studies showed that several different genotypes cocirculated and some predominated in a community every year (23, 27) . However, the relationship between strain diversity and the clinical and epidemiological features of HRSV has yet to be elucidated in detail.
The subgroups have been subdivided further, into genotypes, by genetic analyses. HRSV-A is divided into seven genotypes (GA1 to -7) and HRSV-B into four genotypes (GB1 to -4) (3, 8 ). An additional HRSV-A genotype, SAA1, has been proposed, as well as the new HRSV-B genotypes SAB1 to -3 (37) . Another HRSV-B genotype includes the Buenos Aires (BA) type strain, which has a 60-nucleotide insertion in the second hypervariable region of the G protein and has been reported in Buenos Aires in 1999, as well as in other areas of the world (31, 35, 40) . BA strains are further subdivided into six clusters (BA-I to BA-VI) (36) .
National surveillance of HRSV infection based on weekly reports from sentinel pediatric clinics throughout Japan began 
MATERIALS AND METHODS
HRSV surveillance system in Japan. National surveillance of HRSV infection under the Infectious Disease Control Law began in November, 2003 in Japan (http://idsc.nih.go.jp/iasr/20/230/de2309.html; http://idsc.nih.go.jp/iasr/25/287 /tpc287.html). Each HRSV case is defined on the basis of clinical respiratory symptoms, such as rhinorrhea, wheeze, and cough, and laboratory diagnosis, such as virus isolation, serologic test, or rapid antigen test, is carried out at the outpatient clinic or on admission to the hospital. The number of patients diagnosed with HRSV infection is reported on a weekly basis from approximately 3,000 sentinel pediatric clinics/hospitals throughout Japan. These sentinel sites forward clinical data to approximately 60 prefectural or municipal public health institutes, and the data generated are electronically reported to the Infectious Disease Surveillance Center in the National Institute of Infectious Diseases (Tokyo). The weekly total numbers of HRSV cases in Japan that were released on the web site (http://idsc.nih.go.jp/idwr/index.html) was compiled into monthly data to compare with our clinic survey.
Study population and clinical samples. This study was conducted for six successive seasons, from November 2001 through June 2007, at one pediatric outpatient clinic in Niigata City, Japan. Niigata City is the prefectural capital of Niigata Prefecture, and its total population is approximately 0.8 million. Children under 5 years of age with acute lower respiratory tract illness, such as wheezing, cough, rhinorrhea, and fever, were enrolled in the study. We obtained written informed consent from their guardians and nasopharyngeal aspirates or nasal swabs from the patients. Basic clinical data, such as sex, age, date of clinic visit, and date of onset, were recorded by a pediatrician at the clinic. This study was approved by the Medical Faculty Ethics Committee of Niigata University.
Clinical specimens were kept at 4°C in the clinic; were transported to the Department of Public Health, Graduate School of Medical and Dental Sciences, Niigata University, within 5 days of sampling; and were then kept frozen at Ϫ80°C for further examination.
RT-PCR and nucleotide sequencing. Briefly, for reverse transcription (RT)-PCR and nucleotide sequencing, viral RNA was extracted from 100-l samples of the nasopharyngeal aspirates or swabs by using an Extragen II kit (Kainos, Tokyo, Japan) according to the manufacturer's instructions. RT to create cDNA was performed using random primers and Moloney murine leukemia virus reverse transcriptase (Invitrogen Corp. Carlsbad, CA) (31) .
In accordance with a method previously published (31), first and heminested PCRs targeting a 270-nucleotide segment of the G protein gene's second hypervariable region were performed. Amplified PCR products were purified with a MicroSpin S-300 HR column PCR purification kit (Amersham Bioscience, Buckinghamshire, United Kingdom), labeled with a BigDye terminator (version 3.1) cycle sequencing kit (Applied Biosystems, Foster, CA) according to the manufacturer's instructions, and then analyzed on an ABI 3100 automatic DNA sequencer.
Phylogenetic analysis. Multiple sequence alignments of G genes for HRSV-A and -B strains were complied with BioEdit, version 7.0.9.0 (12) . Phylogenetic trees of the G protein gene's second hypervariable region were generated by using the neighbor-joining method with MEGA, version 4 (34). Bootstrap probabilities for 1,000 iterations were calculated to evaluate confidence estimates. All sequences for both subgroup A and B viruses were included in the phylogenetic analysis. In the phylogeny, strains from Rochester, NY; Winnipeg, Manitoba, Canada; Houston, TX.; St. Louis, MO; Soweto, South Africa; Birmingham, AL; West Virginia; and Buenos Aires, Argentina, were included for comparison. Pairwise nucleotide distances (p distances), that is, the number of pairwise nucleotide differences divided by the total number of nucleotides in the sequenced segment, between representative paired sequences from each genotype of HRSV-A were calculated using MEGA, version 4 (34) .
Patient characteristics by genotypes. Clinical data on patients, such as sex and average age, were compared among seasons and infecting-strain genotypes. Statistical analysis for comparison of mean values in more than three groups was performed by using Scheffe's test. Comparison of the proportions was accomplished with 2-by-multiple tables. Statistical significance was concluded if the P value was less than 0.05.
Deduced amino acids and N-glycosylation site analysis. The deduced amino acid sequences at the second hypervariable region of HRSV-A and HRSV-B strains were compared to those of the prototype A2 strain, spanning 270 nucleotides, and the BA type strain (BA4128/99B), with 330 nucleotides, respectively (16, 35) . Potential N-glycosylation sites were predicted if the encoded amino acids were NXT, where X is not a proline (16, 25, 28) .
Nucleotide sequence accession numbers. The GenBank accession numbers of the nucleotide sequences obtained in the present study are AB470478 to AB470482.
RESULTS
National surveillance of HRSV cases in Japan. National surveillance for HRSV in Japan started in November 2003, and the disease was most prevalent and clearly active during autumn and early winter ( Molecular epidemiology and emergence of new genotype of HRSV in Niigata City. Phylogenetic analysis revealed that 338 samples were HRSV-A and 150 were HRSV-B ( Table 2) . The HRSV-A strains clustered into four genotypes, namely, GA5, GA7, and the two new genotypes NA1 and NA2, with bootstrap values of 70% to 100% (Fig. 2a) . The NA1 and the NA2 strains were genetically close to the GA2 strains. The p distance between each NA1 strain and the representative GA2 strain, which was prototype A2 (M11486), ranged from 0.119 to 0.137, and the p distance between each NA2 strain and the representative GA2 strain ranged from 0.115 to 0.119. Furthermore, the NA1 strains were genetically very close to the NA2 strains, with the p distances between the two groups being 0.041 to 0.070. For reference purposes, the p distances between the HRSV-A and HRSV-B strains in our study were 0.548 to 0.989.
On the other hand, the HRSV-B strains clustered into three genotypes, namely, GB3, SAB3, and BA, with bootstrap values of 70% to 100% (Fig. 2b) . The BA strains, first reported in Buenos Aires in 1999, have a 60-nucleotide insertion in the second hypervariable region of the G protein (35) .
The predominant genotype changed during the study period. Age distribution of children with HRSV infections by genotype. A significant difference in average ages was observed between patients infected with genotypes GA5 and NA2 (1.0 Ϯ 0.8 years old versus 1.7 Ϯ 1.1 years old, P Ͻ 0.001) ( Table 3) b No statistically significant differences in age distribution were shown between seasons in HRSV-positive or -negative patients.
c No statistically significant differences in average ages of HRSV-negative patients were shown between seasons. The proportion of children more than 2 years old infected with NA2 was significantly higher than the proportion infected with GA5 (37.6% versus 15.7%, P Ͻ 0.001). Among patients infected with other genotypes, the proportions were not statistically different (Table 3) .
Amino acid analysis and N-glycosylation sites. Four putative N-glycosylation sites were identified on the second variable region of the G protein among the HRSV-A strains. The first site, amino acid (aa) position 237, was conserved among the GA5 and NA2 strains but disappeared in the NA1 strain. The second site, aa 250, was present in the genotype GA5 strain only; the third site, aa 251, was identified in the prototype A2 and the NA1 strains as having amino acid coding NTT, and the NA2 strain as having NIT. The fourth site, aa 294, was conserved among all the three genotypes. Other amino acid mutations in comparison to the prototype were observed at residues 226, 256, 262, 274, 290, and 297 (Fig. 3a) .
Three N-glycosylation sites were identified among the group B strains (Fig. 3b) . The first site was identified at aa 230 in the BA-V strains only, while the other two sites, at aa 296 and aa 310, were conserved among almost all the strains at the Cterminal end of the G protein gene. Other amino acid mutations in comparison to the prototype were observed at residues 218, 247, 270, and 287 (Fig. 3b) .
Reinfection. Reinfection was defined as an infection that occurred after a month-long period from the first infection without any HRSV clinical manifestation of acute respiratory infection. Over the study period, 39 (8.0%) of 488 patients were documented with HRSV reinfections (Table 4) . Among them, eight (20.5%) were homologous reinfections, four (10.3%) being GA5, three (7.7%) NA2, and one (2.6%) BA. In our study, 20 of 39 reinfections were caused by NA2, the highest frequency of all the genotypes. Of these, the first infection was due to homologous NA2 in three cases, to NA1 and BA strains in eight cases each, and to a GA5 strain in one case. In addition, two novel genotypes, NA1 and NA2, which were GA2 variants of HRSV-A, were detected. The two genotypes were very close to each other but distinguished from GA2 in the phylogenetic tree and pairwise nucleotide distances. HRSV-A (17, 25, 41 ), but the new GA2 variants NA1 and NA2 have not been reported in Japan before. Thus, it was speculated that the large epidemics occurred due to the emergence of NA1 and NA2, because most of the children did not have immunity. We also detected NA2 strains from pediatric samples in Lebanon and Vietnam in 2008 (unpublished data), suggesting that this strain might be circulating globally. However, there are no reports of large outbreaks caused by the GA2 variants in other areas, so further studies are warranted to confirm our findings.
DISCUSSION
In general, most individuals are infected with HRSV in the first year of life and few escape infection by this virus during infancy or early childhood. That is why the age of children infected with HRSV tended to be younger. However, the results of our study indicated that the average age of the HRSV cases during the large outbreak in the 2006-2007 season was significantly older than in the other seasons. Of note, the ages of NA2-infected children were significantly older than the ages of children infected with other genotypes. This could be due to a low level of past immunity against the newly emerged NA2 among most infants and children.
Antigenic variation between and within the subgroups may contribute to reinfections by evading the host immune responses. Almost all homologous HRSV reinfections observed in this study were caused by HRSV-A viruses. This is in line with the findings of previous studies (20, 41) which suggested that HRSV-A may not elicit a complete and/or long-lasting subgroup-specific immune response compared to that elicited by HRSV-B. Interestingly, reinfection caused by NA2 occurred more frequently than reinfections by other genotypes, although it only circulated during two seasons. Thus, our observations led us to surmise that a weaker neutralizing immune response against NA2 was a cause for a higher rate of reinfection with NA2 strains.
However, it was unclear why NA1 was replaced by NA2 and why it did not become the dominant genotype in the following epidemic. Genetically, NA1 strains were very close to NA2 strains, as the p distance between the NA1 and NA2 strains was 0.041 to 0.070. However, several amino acid changes and different N-glycosylation sites in the second hypervariable region on the G protein might have contributed to a change in antigenicity between the genotypes (3, 24) . Yet, this remains to be confirmed by serological studies.
After the appearance of the BA virus, which has a duplication of 60 nucleotides, in the 2002-2003 season (31), BA viruses were in circulation Niigata consistently thereafter. Trento et al. analyzed HRSV-B collected in Buenos Aires and classified the isolates into clusters BA-I to BA-IV by analyzing the entire G gene sequence (36) . Also, they compared a worldwide collection of BA strains by partial sequence analysis of the last 330 nucleotides and reported six clusters, BA-I to BA-VI. In our analysis, we found that three clusters, BA-II, -IV, and -V, circulated during the study period. a For HRSV-A strains, a statistically significant difference in average age was shown between patients with genotypes NA2 and GA5 (P Ͻ 0.001), and a statistically significant higher proportion of patients with genotype NA2 than with GA5 that were Ͼ2 years old (P Ͻ 0.001) was shown.
b For HRSV-B strains, no statistically significant age differences were found between patients with different genotypes. other countries (36) . The reason for the successful circulation of this subgenotype for years remains to be determined.
In conclusion, we found novel emerging genotypes of HRSV-A, namely, NA1 and NA2, in Niigata, Japan. The analysis of both clinical and molecular biological information showed a possible correlation between the emergence of genotype NA2 and higher chances for reinfection, which may eventually lead to large outbreaks of HRSV in Japan. Furthermore, we would like to emphasize the importance of long-term molecular epidemiological surveys for early detection of newly emerging genotypes and the benefit of studies to elucidate the genetic and antigenic mechanisms underlying reinfection for better understanding of HRSV infections. 
